Know Cancer

or
forgot password

Cytoreductive Surgery With Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) - Goal Directed Therapy vs. Standard Fluid Therapy. Prospective Randomized Study


N/A
18 Years
N/A
Not Enrolling
Both
Primary Peritoneal Neoplasm, Secondary Peritoneal Neoplasm

Thank you

Trial Information

Cytoreductive Surgery With Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) - Goal Directed Therapy vs. Standard Fluid Therapy. Prospective Randomized Study


Inclusion Criteria:



- Patients selected for Cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy

Exclusion Criteria:

- Patients under the age of 18, patients with hemodynamically significant aortic
regurgitation and heart rhythm disorders

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

rate of abdominal complications

Outcome Time Frame:

90 day postoperative complication

Safety Issue:

No

Principal Investigator

Ester Forastiere, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Regina Elena CI

Authority:

Italy: AIFA ("Agenzia italiana per il farmaco")

Study ID:

89/10

NCT ID:

NCT01882920

Start Date:

June 2010

Completion Date:

September 2012

Related Keywords:

  • Primary Peritoneal Neoplasm
  • Secondary Peritoneal Neoplasm
  • Cytoreductive surgery
  • hyperthermic intraperitoneal chemotherapy
  • Goal directed fluid therapy
  • Neoplasms
  • Fever
  • Peritoneal Neoplasms

Name

Location